`ESTTA641636
`ESTTA Tracking number:
`11/26/2014
`
`Filing date:
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`91218833
`Defendant
`Fuenmayor, Ricardo A.
`FUENMAYOR, RICARDO A.
`6318 23RD AVE
`BROOKLYN, NY 11204-3305
`
`fuenmayor.ricardo@gmail.com
`Other Motions/Papers
`Ricardo A Fuenmayor
`fuenmayor.ricardo@gmail.com
`/Ricardo A Fuenmayor/
`11/26/2014
`Consented Motion to Amend Goods.pdf(3931696 bytes )
`
`Proceeding
`Party
`
`Correspondence
`Address
`
`Submission
`Filer's Name
`Filer's e-mail
`Signature
`Date
`Attachments
`
`
`
`IN THE U.S. PATENT & TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL & APPEAL BOARD
`
`. Re .: 123.0906
`
`HORUSPHARMA,
`
`O pposer,
`
`v.
`
`RICARDO A. FUENMAYOR,
`
`A pplicant.
`
`O pposition N o. 91218833
`(A pplication
`S erial N o. 86157681)
`
`CONSENTED MOTION TO AMEND
`APPliCANT'S
`IDENTIFICATION
`OF GOODS
`
`RICARDO A. FUENMAYOR,
`
`A pplicant
`
`herein, m oves
`
`to am end
`
`the goods
`
`covered by his A pplication
`
`S erial N o. 86157681 for THORUS in C lass 10 by adding the
`
`follow ing language
`
`to both clauses of A pplicant's
`
`identification
`
`of goods, nam ely,
`
`" ... , all
`
`of the foregoing
`
`excluding
`
`ophthalm ological
`
`products
`
`and devices, derm atological
`
`products
`
`and devices,
`
`anti-infective,
`
`anti-inflam m atory,
`
`antiviral,
`
`anti-allergy,
`
`healing
`
`and edem a
`
`and dry-eye disease products
`
`and devices."
`
`A s published, A pplicant's
`
`identification
`
`of goods currently
`
`reads:IHGFEDCBA
`
`d e v i c e s
`i m p l a n t
`s u r g i c a l a n d m e d i c a l
`d e v i c e s , n a m e l y ,
`B e a u t i f y i n g
`o f a r t i f i c i a l m a t e r i a l s f o r u s e i n c o s m e t i c s u r g e r y f o r
`t h e
`c o m p r i s e d
`o f
`t h e u s e r 's f a c e ,
`s k i n ,
`t h u s m i n i m i z i n g
`h i s / h e r
`u i r i n k l e s .f o r
`s t r e t c h i n g
`t h e s p e c i f i c p u r p o s e
`o f o b t a i n i n g
`a y o u n g e r
`l o o k ; m e d i c a l d e v i c e s ,
`n a m e l y ,
`s u r g i c a l
`i m p l a n t
`d e v i c e s c o m p r i s e d p r i m a r i l y
`o f a r t i f i c i a l
`m a t e r i a l s f o r u s e i n p l a s t i c
`s u r g e r y
`a s c o s m e t i c d e v i c e s f o r
`i m p r o v i n g
`in C lass 10.
`a p p e a r a n c e
`
`C O N S E N T E D M O T IO N T O A M E N D
`
`A P P L IC A N T 'S
`
`ID E N T IF IC A T IO N
`
`O F G O O D S
`
`
`
`~ ~ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - .......,.
`
`A redlined version of the am endm ent
`
`follow s:IHGFEDCBA
`
`Q P P O S IT IO N N o· 91218833
`(A P P L IC A T IO N S E R IA L N o. 86157681)
`
`d e v i c e s
`i m p l a n t
`s u r g i c a l a n d m e d i c a l
`d e v i c e s , n a m e l y ,
`B e a u t i f y i n g
`o f a r t i f i c i a l m a t e r i a l s f o r u s e in c o s m e t i c
`s u r g e r y f o r
`t h e
`c o m p r i s e d
`o f
`t h e u s e r 's f a c e ,
`s k i n ,
`t h u s m i n i m i z i n g
`h i s / h e r u i r i n k l e s . f o r
`s t r e t c h i n g
`l o o k , all o f t h e foregoing
`t h e s p e c i f i c p u r p o s e
`o f o b t a i n i n g
`a y o u n g e r
`excluding ophthalmological products and devices,
`dermatological products and devices, anti-infective, anti-
`inflammatory, antiviral, anti-allergy, healing and edema and
`dry-eye d i s e a s e p r o d u c t s and devices; m e d i c a l d e v i c e s , n a m e l y ,
`s u r g i c a l
`i m p l a n t d e v i c e s c o m p r i s e d p r i m a r i l y
`o f a r t i f i c i a l m a t e r i a l s f o r
`a p p e a r a n c e , all
`u s e i n p l a s t i c
`s u r g e r y
`a s c o s m e t i c d e v i c e s f o r
`i m p r o v i n g
`o f t h e foregoing excluding o p h t h a l m o l o g i c a l
`p r o d u c t s and
`devices, dermatological products and devices, anti-infective,
`anti-inflammatory, antiviral, anti-allergy, healing and edema
`and dry-eye disease products and devices in C lass 1 0 .
`
`A ccordingly, the final identification of goods for A pplication S erial N o. 86157681
`
`w ill read as follow s:
`
`d e v i c e s
`i m p l a n t
`s u r g i c a l a n d m e d i c a l
`d e v i c e s , n a m e l y ,
`B e a u t i f y i n g
`f o r 'U s e in c o s m e t i c s u r g e r y f o r
`t h e
`o f a r t i f i c i a l m a t e r i a l s
`c o m p r i s e d
`o f
`t h e u s e r 's f a c e ,
`s k i n ,
`t h u s m i n i m i z i n g
`h i s / h e r w r i n k l e s ,f o r
`s t r e t c h i n g
`t h e s p e c i f i c p u r p o s e
`o f o b t a i n i n g
`a y o u n g e r
`l o o k , a l l o f
`t h e f o r e g o i n g
`e x c l u d i n g o p h t h a l m o l o g i c a l
`p r o d u c t s
`a n d d e v i c e s , d e r m a t o l o g i c a l
`a n t i -
`p r o d u c t s
`a n d d e v i c e s , a n t i - i n f e c t i v e ,
`a n t i - i n f l a m m a t o r y ,
`a n t i v i r a l ,
`a l l e r g y , h e a l i n g a n d e d e m a a n d d r y - e y e
`d i s e a s e p r o d u c t s
`a n d d e v i c e s ;
`m e d i c a l d e v i c e s , n a m e l y ,
`s u r g i c a l
`i m p l a n t
`d e v i c e s c o m p r i s e d p r i m a r i l y
`f o r u s e in p l a s t i c
`a r t i f i c i a l m a t e r i a l s
`s u r g e r y
`a s c o s m e t i c d e v i c e s f o r
`i m p r o v i n g
`a p p e a r a n c e ,
`a l l o f
`t h e f o r e g o i n g
`e x c l u d i n g o p h t h a l m o l o g i c a l
`p r o d u c t s
`a n d d e v i c e s , d e r m a t o l o g i c a l
`p r o d u c t s
`a n d d e v i c e s , a n t i -
`i n f e c t i v e , a n t i - i n f l a m m a t o r y ,
`a n t i v i r a l ,
`a n t i - a l l e r g y ,
`h e a l i n g a n d e d e m a
`a n d d e v i c e s in C lass 1 0 .
`a n d d r y - e y e
`d i s e a s e p r o d u c t s
`
`o f
`
`O pposer m akes no am endm ent
`
`to the goods and services covered by its
`
`A pplication S erial N o. 79128753.
`
`"If an am endm ent
`
`is filed in an application that
`
`is the subject of an opposition,
`
`the B oard has jurisdiction over the application and w ill determ ine the propriety of the
`
`C O N S E N T E D M O T IO N T O A M E N D
`
`A P P L IC A N T 'S ID E N T IF IC A T IO N O F G O O D S
`
`P age 2 of 4
`
`
`
`O P P O S IT IO N No. 91218833
`(A P P U C A T IO N S E R IA L No. 86157681)
`
`am endm ent. O nce an opposition has com m enced,
`
`the application that
`
`is the subject of
`
`the opposition m ay not be am ended in substance,IHGFEDCBA
`e x c e p t w i t h t h e c o n s e n t o f
`
`t h e o t h e r
`
`p a r t y
`
`o r p a r t i e s
`
`a n d t h e a p p r o v a l
`
`o f
`
`t h e B o a r d , or upon m otion granted by the B oard."
`
`37 C F R § 2.133; T B M P § 212.07; T B M P § 514 (em phasis added).
`
`O pposer does not object and affirm atively consents to the proposed am endm ent
`
`as recited s u p r a .
`
`T he B oard is em pow ered to accept the consented am endm ent
`
`and to am end the
`
`identification of goods and the opposed application accordingly. T B M P § 514.01; S e e
`
`H a c h e t t e F i l i p a c c h i P r e s s e v . E l l e B e l l e L L C , 85 U S P Q 2d iooo, 1095 (T T A B 2007)
`
`(B oard has jurisdiction to determ ine propriety of am endm ent;
`
`subsequent attem pt by
`
`registrant
`
`to delete goods on w hich m ark has never been used through the P ost
`
`R egistration S ection B ranch is irrelevant);
`
`I n r e P a m e x F o o d s , I n c ., 20g U S P Q 275, 277
`
`(C om m 'r 1980) (T radem ark E xam ining O peration acted beyond its authority in denying
`
`am endm ent
`
`to registration w hich B oard had already approved).
`
`T he P arties believe that republication of A pplication S erial N o. 86157681 is not
`
`required.
`
`U pon approval of the proposed am endm ent,
`
`the P arties w ill prom ptly file a
`
`stipulated w ithdraw al of the instant opposition.
`
`A ssum ing the B oard, approves and accepts A pplicant's proposed am endm ent,
`
`the
`
`B oard m ay dism iss A pplicant's M O T IO NT o A M E N DM A R KR E G IS T R A T IO N(D kt. 5), filed
`
`N ovem ber 18, 2014 and the relevant portions of O pposer's
`
`response thereto (D kt. 6),
`
`filed N ovem ber 21, 2014, as m oot.
`
`C O N S E N T E D M O T IO N T O A M E N D
`
`A P P U C A N T 'S ID E N T IF IC A T IO N O F G O O D S
`
`P age 3 of a
`
`
`
`F or the foregoing reasons,
`
`the P arties respectfully request
`
`that
`
`the B oard approve
`
`the proposed am endm ent
`
`as soon as practicable.
`
`O P P O S IT IO N No. 91218833
`(A P P L IC A T IO N S E R IA L No. 8615768:!)
`
`I
`
`R espectfully subm itted,
`
`D ated: N ovem ber 2 6 ,2 0 1 4
`
`B y:
`
`D ated: N ovem ber 2 6 ,2 0 1 4
`
`B y:
`
`ard
`. M athew L orn
`tilarren M . G eliebter
`L O M B A R D & G E L IE B T E R L L P
`1 1 1 5 B roadw ay
`1 2 th F loor
`N ew Y ork, N ew Y ork 1 0 0 1 0
`9 1 7 · 7 7 9 · 9 9 6 7IHGFEDCBA
`A t t o r n e y s
`f o r O p p o s e r
`
`C O N S E N T E D M O T IO N T O A M E N D
`
`A P P L IC A N T 'S ID E N T IF IC A T IO N O F G O O D S
`
`P age 4 of 4
`
`
`
`CERTIFICATE OF SERVICEedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
`
`I hereby certify that a true and correct copy of the C O N S E N T E D M O T IO N T O A M E N D
`ID E N T IF IC A T IO N O F G oO D S w as served on the follow ing individuals at the
`A P P L IC A N T 'S
`this 26 th day of
`follow ing addresses of record, by first class m ail, postage prepaid,
`N ovem ber 2 0 1 4 :
`
`G . M A T H E W L O M B A R D
`L O M B A R D & G E L IE B T E R L L P
`1 1 1 5 B R O A D W A Y
`1 2 F L O O R
`N E W Y O R K , N Y 1 0 0 1 0